Cervical carcinoma (squamous predominant + adeno) · None
Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.
Knowledge-base record for audit. Provisional clinical content: this is not a prescription. An oncologist must verify original sources, applicability and review status. Full rules and constraints are in the YAML.
| Track | aggressive |
|---|---|
| Linked regimen | None |
| ID | IND-REPRODUCTIVE-DES-EXPOSURE-PREVENTION-OBSERVATION |
|---|---|
| Type | Indication |
| Status | reviewed 2026-05-19 | pending_clinical_signoff |
| Diseases | DIS-CERVICAL |
| Sources | SRC-NCCN-CERVICAL-2025 SRC-USPSTF-CERVICAL-2018 |
Notes
STUB — v0.3 reproductive prevention expansion. Two-Co-Lead signoff queued per CHARTER §6.1 dev-mode. Aggressive track here means "less aggressive surveillance, accept higher residual risk" — naming convention follows existing prevention indications where aggressive = alternative track. Track invariant satisfied: standard (intensified surveillance) + aggressive (general-population schedule).
Used By
No reverse references found in the YAML corpus.